Study protocol: the DESPATCH study: Delivering stroke prevention for patients with atrial fibrillation - a cluster randomised controlled trial in primary healthcare

Rivaroxaban—Once daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: Rationale and Design of the ROCKET AF study

(2010)   AMERICAN HEART JOURNAL

Are Atrial Fibrillation Patients Receiving Warfarin in Accordance with Stroke Risk?

(2010) Peter J. Zimetbaum et al.   AMERICAN JOURNAL OF MEDICINE

Risk of Bleeding With Single, Dual, or Triple Therapy With Warfarin, Aspirin, and Clopidogrel in Patients With Atrial Fibrillation

(2010) Morten L. Hansen et al.   ARCHIVES OF INTERNAL MEDICINE

Rationale and design of RE-LY: Randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran

(2009) Michael D. Ezekowitz et al.   AMERICAN HEART JOURNAL

Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation

(2008) Andrea Rubboli et al.   ANNALS OF MEDICINE

The management of non-valvular atrial fibrillation (NVAF) in Australian general practice: bridging the evidence-practice gap. A national, representative postal survey

(2008) Melina Gattellari et al.   BMC Family Practice

Anticoagulant usage for primary stroke prevention: A general practitioner survey in local areas of metropolitan Sydney

(2007) Qing Shen et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Barriers to the Use of Anticoagulation for Nonvalvular Atrial Fibrillation

(2007) Melina Gattellari et al.   STROKE